Huntington's Disease: A Review of the Known PET Imaging Biomarkers and Targeting Radiotracers.

Biomarkers / metabolism Brain / diagnostic imaging Cannabinoid Receptor Agonists / metabolism Carbon Radioisotopes / chemistry Dopamine Antagonists / chemical synthesis Excitatory Amino Acid Antagonists / chemical synthesis Fluorine Radioisotopes / chemistry GABA Antagonists / chemical synthesis Humans Huntington Disease / diagnostic imaging Microglia / metabolism Phosphodiesterase Inhibitors / chemical synthesis Positron-Emission Tomography Purinergic P1 Receptor Antagonists / chemical synthesis Radiopharmaceuticals / chemistry
Huntington’s disease Positron Emission Tomography [11C]raclopride [18F]MNI-659 carbon-11 fluorine-18 mutant huntingtin radiochemistry radiopharmaceuticals

Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
23 Jan 2020
Historique:
received: 18 12 2019
revised: 14 01 2020
accepted: 15 01 2020
entrez: 26 1 2020
pubmed: 26 1 2020
medline: 28 11 2020
Statut: epublish

Résumé

Huntington's disease (HD) is a fatal neurodegenerative disease caused by a CAG expansion mutation in the

Identifiants

DOI: 10.3390/molecules25030482 PMID: 31979301 PMC: PMC7038198
pubmed: 31979301
pii: molecules25030482
doi: 10.3390/molecules25030482
pmc: PMC7038198
pii:
doi:

Substances chimiques

Biomarkers 0
Cannabinoid Receptor Agonists 0
Carbon Radioisotopes 0
Dopamine Antagonists 0
Excitatory Amino Acid Antagonists 0
Fluorine Radioisotopes 0
GABA Antagonists 0
Phosphodiesterase Inhibitors 0
Purinergic P1 Receptor Antagonists 0
Radiopharmaceuticals 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

Ageing Res Rev. 2019 Jan;49:92-103
pubmed: 30502498
Brain. 1999 Dec;122 ( Pt 12):2353-63
pubmed: 10581228
CNS Neurosci Ther. 2018 Apr;24(4):292-300
pubmed: 29464851
Alzheimers Dement (N Y). 2017 Aug 30;3(4):481-486
pubmed: 29124105
J Nucl Med. 2014 Apr;55(4):595-601
pubmed: 24614221
J Nucl Med. 2014 Aug;55(8):1297-304
pubmed: 24898025
J Med Chem. 2011 Aug 25;54(16):5820-35
pubmed: 21777010
Genetics. 2017 Feb;205(2):503-516
pubmed: 27913616
Ann Nucl Med. 2002 Nov;16(7):467-75
pubmed: 12508837
Int J Mol Sci. 2017 Apr 07;18(4):
pubmed: 28387722
Front Cell Neurosci. 2017 Jan 04;10:294
pubmed: 28101004
Int J Appl Radiat Isot. 1985 Apr;36(4):269-73
pubmed: 3874833
Brain Sci. 2017 Jun 07;7(6):
pubmed: 28590448
J Nucl Med. 2006 Apr;47(4):698-705
pubmed: 16595505
Eur J Nucl Med Mol Imaging. 2016 Jun;43(6):1171-82
pubmed: 26899245
Brain. 2015 Oct;138(Pt 10):3016-29
pubmed: 26198591
Contrast Media Mol Imaging. 2017 Nov 20;2017:6975841
pubmed: 29348737
Int J Rad Appl Instrum B. 1989;16(1):47-50
pubmed: 2654085
Nucl Med Commun. 2011 Nov;32(11):1011-7
pubmed: 21897309
Open Biol. 2018 Dec 5;8(12):
pubmed: 30518638
Steroids. 2011 Nov;76(12):1331-40
pubmed: 21756927
J Nucl Med. 2000 Feb;41(2):345-54
pubmed: 10688121
Neurotherapeutics. 2012 Apr;9(2):270-84
pubmed: 22441874
Ann Neurol. 2000 May;47(5):644-8
pubmed: 10805336
Mol Pharmacol. 2012 Aug;82(2):199-208
pubmed: 22554805
ChemMedChem. 2014 Apr;9(4):693-8
pubmed: 24446373
Sci Signal. 2017 Dec 19;10(510):
pubmed: 29259100
Neuroscience. 2000;97(3):505-19
pubmed: 10828533
J Nucl Med. 2007 Feb;48(2):247-52
pubmed: 17268022
Lancet Neurol. 2003 Jun;2(6):366-74
pubmed: 12849153
J Nucl Med. 2010 Sep;51(9):1413-7
pubmed: 20720046
Lancet. 2014 Aug 9;384(9942):545-55
pubmed: 24954676
Ann Neurol. 1998 Feb;43(2):253-5
pubmed: 9485067
EJNMMI Res. 2018 Aug 2;8(1):74
pubmed: 30069645
Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4604-9
pubmed: 10200309
AJNR Am J Neuroradiol. 2014 Jun;35(6):1070-2
pubmed: 24231851
J Med Chem. 2002 Nov 7;45(23):5150-6
pubmed: 12408725
CNS Drug Rev. 2001 Winter;7(4):399-414
pubmed: 11830757
Drug Discov Today Technol. 2017 Nov;25:45-52
pubmed: 29233267
J Neurosci. 2010 Jan 6;30(1):316-24
pubmed: 20053912
J Cereb Blood Flow Metab. 2019 Jul 15;:271678X19864081
pubmed: 31307287
Int J Rad Appl Instrum A. 1986;37(10):1039-43
pubmed: 3027000
Hum Brain Mapp. 2011 Feb;32(2):258-70
pubmed: 21229614
Nat Neurosci. 2018 Oct;21(10):1359-1369
pubmed: 30258234
Neuroscience. 1993 Oct;56(3):523-7
pubmed: 8255419
J Nucl Med. 2016 May;57(5):777-84
pubmed: 26848175
Neurology. 2014 Jan 21;82(3):279-81
pubmed: 24353339
Synapse. 2007 Aug;61(8):595-605
pubmed: 17455247
J Nucl Med. 2018 Nov;59(11):1722-1727
pubmed: 29794227
Brain. 2007 Jul;130(Pt 7):1759-66
pubmed: 17400599
Ann Nucl Med. 2008 Jun;22(5):417-24
pubmed: 18600420
J Med Chem. 2009 Feb 12;52(3):688-99
pubmed: 19119848
Hum Brain Mapp. 2011 Oct;32(10):1626-36
pubmed: 20886576
Pediatr Neurol. 2019 Nov;100:12-25
pubmed: 31416725
Eur J Nucl Med Mol Imaging. 2011 Jun;38(6):1083-94
pubmed: 21279350
Neurobiol Dis. 2010 Feb;37(2):356-61
pubmed: 19853661
Nucl Med Biol. 2017 Dec;55:v-xi
pubmed: 29074076
J Nucl Med. 2010 Jan;51(1):145-9
pubmed: 20008980
Hum Mol Genet. 2018 Aug 15;27(16):2893-2912
pubmed: 29860333
J Nucl Med. 2013 Aug;54(8):1285-93
pubmed: 23843566
Neurosci Lett. 2019 Jan 19;691:11-17
pubmed: 30099081
J Nucl Med. 2003 Oct;44(10):1682-9
pubmed: 14530487
J Huntingtons Dis. 2015;4(4):287-96
pubmed: 26683130
J Labelled Comp Radiopharm. 2014 Aug;57(10):611-4
pubmed: 25156811
Cell. 2019 Aug 8;178(4):887-900.e14
pubmed: 31398342
Mol Cell Neurosci. 2019 Jun;97:34-42
pubmed: 30796959
Front Neurol. 2017 Jan 30;8:11
pubmed: 28194132
Neurology. 2016 Feb 23;86(8):748-54
pubmed: 26802091
Expert Opin Ther Targets. 2014 Nov;18(11):1293-304
pubmed: 25118797
Biochim Biophys Acta. 2011 May;1808(5):1380-99
pubmed: 21145878
Sci Rep. 2017 Jan 27;7:41432
pubmed: 28128287
Eur J Nucl Med Mol Imaging. 2014 Jun;41(6):1210-20
pubmed: 24566949
JAMA Neurol. 2014 Dec;71(12):1520-8
pubmed: 25322077
Int J Rad Appl Instrum A. 1987;38(5):345-8
pubmed: 3038787
Neuroscience. 2004;123(4):967-81
pubmed: 14751289
J Neurochem. 2016 Dec;139(5):897-906
pubmed: 27664396
Eur Arch Psychiatry Clin Neurosci. 1994;243(5):249-55
pubmed: 8172940
J Nucl Med. 1998 Dec;39(12):2061-8
pubmed: 9867142
Eur J Pharmacol. 1985 Feb 5;108(3):327-8
pubmed: 3886409
J Nucl Med. 2017 Apr;58(4):617-622
pubmed: 27856625
Eur J Nucl Med Mol Imaging. 2013 Jan;40(2):254-61
pubmed: 23160998
J Caffeine Adenosine Res. 2018 Jun 1;8(2):43-58
pubmed: 30023989
Curr Neurol Neurosci Rep. 2018 Oct 5;18(12):85
pubmed: 30291526

Auteurs

Klaudia Cybulska (K)

Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Geert Grooteplein-Zuid 10, 6525 EZ Nijmegen, The Netherlands.
Radboud Translational Medicine B.V., Radboud University Medical Center, Geert Grooteplein 21 (route 142), 6525 EZ Nijmegen, The Netherlands.

Lars Perk (L)

Radboud Translational Medicine B.V., Radboud University Medical Center, Geert Grooteplein 21 (route 142), 6525 EZ Nijmegen, The Netherlands.

Jan Booij (J)

Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Geert Grooteplein-Zuid 10, 6525 EZ Nijmegen, The Netherlands.
Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.

Peter Laverman (P)

Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Geert Grooteplein-Zuid 10, 6525 EZ Nijmegen, The Netherlands.

Mark Rijpkema (M)

Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Geert Grooteplein-Zuid 10, 6525 EZ Nijmegen, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Facteurs biologiques › Marqueurs biologiques › Huntington's Disease: A Review of the Known...
questionsmedicales.fr › Système nerveux › Système nerveux central › Encéphale › Huntington's Disease: A Review of the Known...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Effets physiologiques des médicaments › Hormones, substituts d'hormones et antagonistes d'hormones › Hormones › Modulateurs des récepteurs de cannabinoïdes › Agonistes des récepteurs de cannabinoïdes › Huntington's Disease: A Review of the Known...
questionsmedicales.fr › Produits chimiques inorganiques › Isotopes › Radio-isotopes › Radio-isotopes du carbone › Huntington's Disease: A Review of the Known...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Effets physiologiques des médicaments › Agents neuromédiateurs › Agents dopaminergiques › Antagonistes de la dopamine › Huntington's Disease: A Review of the Known...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Effets physiologiques des médicaments › Agents neuromédiateurs › Agents des acides aminés excitateurs › Antagonistes des acides aminés excitateurs › Huntington's Disease: A Review of the Known...
questionsmedicales.fr › Produits chimiques inorganiques › Isotopes › Radio-isotopes › Radio-isotopes du fluor › Huntington's Disease: A Review of the Known...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Effets physiologiques des médicaments › Agents neuromédiateurs › Agents GABA › Antagonistes GABA › Huntington's Disease: A Review of the Known...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Huntington's Disease: A Review of the Known...
questionsmedicales.fr › Troubles mentaux › Troubles neurocognitifs › Démence › Maladie de Huntington › Huntington's Disease: A Review of the Known...
questionsmedicales.fr › Cellules › Névroglie › Microglie › Huntington's Disease: A Review of the Known...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Mécanismes moléculaires de l'action pharmacologique › Antienzymes › Inhibiteurs de la phosphodiestérase › Huntington's Disease: A Review of the Known...
questionsmedicales.fr › Diagnostic › Techniques et procédures diagnostiques › Techniques de diagnostic radioisotopique › Scintigraphie › Tomoscintigraphie › Tomographie par émission de positons › Huntington's Disease: A Review of the Known...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Effets physiologiques des médicaments › Agents neuromédiateurs › Agents purinergiques › Antagonistes purinergiques › Antagonistes des récepteurs purinergiques P1 › Huntington's Disease: A Review of the Known...
questionsmedicales.fr › Actions chimiques et utilisations › Utilisations spécialisées de produits chimiques › Produits chimiques de laboratoire › Indicateurs et réactifs › Radiopharmaceutiques › Huntington's Disease: A Review of the Known...